<drug type="small molecule" created="2015-11-30" updated="2016-08-30">
  <drugbank-id primary="true">DB09420</drugbank-id>
  <name>Sodium iodide I-123</name>
  <description>Sodium Iodide I-123 is a radioactive isotope of iodine used in nuclear medicine for the diagnostic study of thyroid disease. Following oral administration, I-123 is absorbed through the gastrointestinal tract  and is taken up by the thyroid gland. After incorporation, a gamma camera is used to detect the decay by electron capture to tellurium-123.&#13;
&#13;
Iodine is commonly used in thyroid function diagnostic tests as this gland normally absorbs iodine through the diet for formation of the thyroid hormones triiodothyronine (T3) and its prohormone, thyroxine (T4). Radioactive I-123 in particular is effective for this use as its half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and it has a reduced radiation burden as compared to I-131.</description>
  <cas-number>69239-56-1</cas-number>
  <unii>98QPV8670C</unii>
  <average-mass>122.9061</average-mass>
  <monoisotopic-mass>122.906146524</monoisotopic-mass>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference/>
  <indication>Administration of Sodium Iodide I 123 Capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.</indication>
  <pharmacodynamics/>
  <mechanism-of-action>Sodium Iodide I-123 is a radioactive isotope of iodine used in nuclear medicine for the diagnostic study of thyroid disease. Following oral administration, I-123 is absorbed through the gastrointestinal tract  and is taken up by the thyroid gland. After incorporation, a gamma camera is used to detect the decay by electron capture to tellurium-123. Iodine is commonly used in thyroid function diagnostic tests as this gland normally absorbs iodine through the diet for formation of the thyroid hormones triiodothyronine (T3) and its prohormone, thyroxine (T4).</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life>Iodine-123 decays by electron capture with a physical half-life of 13.2 hours</half-life>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as homogeneous halogens. These are inorganic non-metallic compounds in which the largest atom is a nobel gas.</description>
    <direct-parent>Homogeneous halogens</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Inorganic compounds</superclass>
    <class>Homogeneous non-metal compounds</class>
    <subclass>Homogeneous halogens</subclass>
    <substituent>Homogeneous halogen</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">123Iâˆ’</synonym>
    <synonym language="" coder="">I 123</synonym>
    <synonym language="" coder="">I-123</synonym>
    <synonym language="" coder="">Iodine 123</synonym>
    <synonym language="" coder="">Iodine-123</synonym>
    <synonym language="" coder="">Sodium iodide I 123</synonym>
    <synonym language="" coder="">Sodium iodide I123</synonym>
  </synonyms>
  <products>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Mallinckrodt Nuclear Medicine Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69945-601</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-11-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>100 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA071909</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Mallinckrodt Nuclear Medicine Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69945-602</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-04-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>200 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA071910</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Cardinal Health 418, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>48815-1001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>100 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018671</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Cardinal Health 418, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>48815-1002</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>200 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018671</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>0019-9601</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-04-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>100 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA071909</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Iodide I 123</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>0019-9602</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-04-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>200 uCi/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA071910</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Iodide I 123</name>
      <ingredients>Sodium iodide I-123</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength>100 uCi/1</strength>
    </dosage>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength>200 uCi/1</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <fda-label>https://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB09420.pdf?1472581786</fda-label>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>1.02</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(123I)iodide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>(123I)iodide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>122.9061</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>122.906146524</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[123I-]</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>I</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/HI/h1H/p-1/i1-4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>XMBWDFGMSWQBCA-AHCXROLUSA-M</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>13.95</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>5.07</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>-9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Iodine-123</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1249</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/sodium-iodide-i-131-drug/indications-dosage.htm</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>https://www.drugs.com/pro/sodium-iodide-i-123.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
